BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Indo US Bio-Tech Ltd Industry :  Miscellaneous
BSE Code
541304
ISIN Demat
INE250Z01010
Book Value (Rs)
46.1460203
NSE Symbol
INDOUS
Divident Yield %
0
Market Cap
(Rs In Cr.)
120
P/E (TTM)
10.51
EPS (TTM)
5.71
Face Value
(Rs)
10
Back
Indo US Bio-Tech standalone net profit declines 46.47% in the March 2026 quarter
01-Jun-26   Hrs IST

Net profit of Indo US Bio-Tech declined 46.47% to Rs 1.97 crore in the quarter ended March 2026 as against Rs 3.68 crore during the previous quarter ended March 2025. Sales declined 22.05% to Rs 26.02 crore in the quarter ended March 2026 as against Rs 33.38 crore during the previous quarter ended March 2025.

For the full year,net profit declined 19.36% to Rs 13.12 crore in the year ended March 2026 as against Rs 16.27 crore during the previous year ended March 2025. Sales rose 6.36% to Rs 110.44 crore in the year ended March 2026 as against Rs 103.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales26.0233.38 -22 110.44103.84 6
OPM %12.4113.69 -15.4018.24 -
PBDT2.654.43 -40 14.8217.63 -16
PBT2.383.87 -39 13.9216.53 -16
NP1.973.68 -46 13.1216.27 -19

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)